Table 1 (abstract P108). See text for description
From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
|  | Group 1 n=5 Normal MRI | Group 2 n=16 Score >1 to 24 (median±SD 21±5.7) | Group 3 n=9 Score >24 to 72 (median±SD 36±9.78) | p |
|---|---|---|---|---|
Age at study* | 10(5-17) | 12 (9-16) | 14 (7-17) | 0.001 |
Duration of disease* | 2 (0-5) | 4(1-8) | 4(2-6) | 0.02 |
AJ* | 1 (0-5) | 1(0-16) | 2(0-8) | ns |
SIP ** | 3 (60) | 8 (50) | 5(56) | ns |
LP** | 1(20) | 12(75) | 4 (44) | ns |
LL ** | 5 (4.5-5.5) | 4.5 (3-7) | 5 (3.5-6) | ns |